A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia

Journal of Clinical Lipidology

Volumn 5, Issue 2, 2011, Pages 76-81

  Davidson, Michael H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adolescent; Bile acid sequestrant; Children; Efficacy; Familial hypercholesterolemia; Pharmacotherapy; Safety; Tolerability

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; STATIN;

ABDOMINAL PAIN; APPETITE; CHILD; COMBINATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DRUG ACTIVITY; DRUG BINDING; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FAMILIAL HYPERCHOLESTEROLEMIA; FATIGUE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HUMAN; LOW DRUG DOSE; MONOTHERAPY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

BILE ACIDS AND SALTS; CHILD; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPOLIPIDEMIC AGENTS;

EID: 79952529811     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.01.005     Document Type: Review

References (17)

1. H.J. Avis, M.N. Vissers, F.A. Wijburg, J.J. Kastelein, and B.A. Hutten The use of lipid-lowering drug therapy in children and adolescents Curr Opin Investig Drugs 10 2009 224 231
2. A. van der Graaf, J.J. Kastelein, and A. Wiegman Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention J Inherit Metab Dis 32 2009 699 705
3. F. Civeira Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia Atherosclerosis 173 2004 55 68 (Pubitemid 38224196)
4. S.R. Daniels, and F.R. Greer Lipid screening and cardiovascular health in childhood Pediatrics 122 2008 198 208
5. W. Insull Jr. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review South Med J 99 2006 257 273
6. T.A. Jacobson, A. Armani, J.M. McKenney, and J.R. Guyton Safety considerations with gastrointestinally active lipid-lowering drugs Am J Cardiol 99 2007 47C 55C
7. D.M. Robinson, and G.M. Keating Colesevelam: a review of its use in hypercholesterolemia Am J Cardiovasc Drugs 7 2007 453 465 (Pubitemid 350256054)
8. S. Tonstad, M. Sivertsen, L. Aksnes, and L. Ose Low dose colestipol in adolescents with familial hypercholesterolaemia Arch Dis Child 74 1996 157 160 (Pubitemid 26057700)
9. S. Tonstad, and L. Ose Colestipol tablets in adolescents with familial hypercholesterolaemia Acta Paediatr 85 1996 1080 1082 (Pubitemid 26302769)
10. S. Tonstad, J. Knudtzon, M. Sivertsen, H. Refsum, and L. Ose Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia J Pediatr 129 1996 42 49 (Pubitemid 26277245)
11. B.W. McCrindle, M.B. O'Neill, G. Cullen-Dean, and E. Helden Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial J Pediatr 130 1997 266 273 (Pubitemid 27495163)
12. E.A. Stein, A.D. Marais, and T. Szamosi Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia J Pediatr 156 2010 231-236. e1-3
13. L. Iughetti, B. Predieri, F. Balli, and S. Calandra Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review J Endocrinol Invest 30 2007 700 719 (Pubitemid 350104102)
14. Y.S. Moon, and M.L. Kashyap Pharmacologic treatment of type 2 diabetic dyslipidemia Pharmacotherapy 24 2004 1692 1713 (Pubitemid 39578959)
15. B.W. McCrindle, E. Helden, G. Cullen-Dean, and W.T. Conner A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia Pediatr Res 51 2002 715 721 (Pubitemid 34547334)
16. R.E. Kavey, V. Allada, and S.R. Daniels Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics Circulation 114 2006 2710 2738
17. B.W. McCrindle, E.M. Urbina, and B.A. Dennison Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing Circulation 115 2007 1948 1967 (Pubitemid 46598908)